🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 4 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
03/08/2021 68,18 68,80 66,07 66,75 -1,85% 4,00% 558.600
02/08/2021 69,54 71,00 67,95 68,01 -1,85% 4,39% 528.100
30/07/2021 67,83 69,54 67,59 69,29 +1,42% 2,87% 537.900
29/07/2021 69,70 70,97 68,02 68,32 -0,07% 4,23% 629.000
28/07/2021 66,31 68,59 65,38 68,37 +3,67% 4,84% 671.400
27/07/2021 66,58 66,58 64,07 65,95 -1,17% 3,77% 485.100
26/07/2021 68,20 68,75 66,24 66,73 -2,40% 3,68% 855.600
23/07/2021 67,97 68,63 66,56 68,37 +0,66% 3,05% 408.300
22/07/2021 68,25 69,16 66,51 67,92 -0,24% 3,88% 456.600
21/07/2021 67,92 68,75 65,97 68,08 +0,25% 4,09% 536.000
20/07/2021 65,66 68,11 65,51 67,91 +3,60% 3,96% 906.300
19/07/2021 62,35 66,15 62,11 65,55 +3,34% 6,48% 854.400
16/07/2021 63,73 64,60 62,26 63,43 +0,44% 3,67% 516.700
15/07/2021 62,56 63,34 61,59 63,15 +0,98% 2,80% 478.700
14/07/2021 63,92 63,92 61,69 62,54 -1,37% 3,49% 741.600
13/07/2021 65,01 65,60 63,32 63,41 -3,60% 3,51% 570.800
12/07/2021 67,14 68,73 65,64 65,78 -2,03% 4,60% 491.900
09/07/2021 65,81 67,46 64,73 67,14 +2,79% 4,15% 799.300
08/07/2021 62,35 66,01 61,51 65,32 +2,49% 7,23% 923.600
07/07/2021 62,68 64,31 61,53 63,73 +1,05% 4,42% 1.517.500
06/07/2021 65,01 67,44 62,19 63,07 -0,10% 8,07% 2.710.100
02/07/2021 67,04 69,25 60,00 63,13 -25,69% 13,80% 7.343.100
01/07/2021 82,71 86,01 82,20 84,96 +2,58% 4,61% 685.600
30/06/2021 81,01 84,31 81,00 82,82 +1,62% 4,09% 646.000
29/06/2021 86,00 86,48 81,47 81,50 -5,47% 5,83% 1.119.900
28/06/2021 89,41 91,00 85,93 86,22 -4,54% 5,67% 776.000
25/06/2021 89,34 90,44 88,30 90,32 +0,90% 2,39% 1.632.900
24/06/2021 88,69 90,41 88,48 89,51 +1,61% 2,17% 705.800
23/06/2021 90,00 93,66 87,35 88,09 -0,83% 7,01% 1.052.300
22/06/2021 89,22 89,63 87,52 88,83 -1,09% 2,36% 723.300